Skip to main content


Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage: a meta-analysis of epidemiologic studies

Article metrics



Studies investigating the association between the apolipoprotein E (APOE) gene polymorphism and the risk of intracerebral hemorrhage (ICH) have reported conflicting results. We here performed a meta-analysis based on the evidence currently available from the literature to make a more precise estimation of this relationship.


Published literature from the National Library of Medline and Embase databases were retrieved. Odds ratio (OR) and 95% confidence interval (CI) were calculated in fixed- or random-effects models when appropriate. Subgroup analyses were performed by race.


This meta-analysis included 11 case–control studies, which included 1,238 ICH cases and 3,575 controls. The combined results based on all studies showed that ICH cases had a significantly higher frequency of APOE ϵ4 allele (OR= 1.42, 95% CI= 1.21,1.67, P<0.001). In the subgroup analysis by race, we also found that ICH cases had a significantly higher frequency of APOE ϵ4 allele in Asians (OR= 1.52, 95% CI= 1.20,1.93, P<0.001) and in Caucasians (OR= 1.34, 95% CI= 1.07,1.66, P=0.009). There was no significant relationship between APOE ϵ2 allele and the risk of ICH.


Our meta-analysis suggested that APOE ϵ4 allele was associated with a higher risk of ICH.


Intracerebral hemorrhage (ICH) occurs at an annual incidence rate of 15 to 19 per 100,000 [1]. ICH accounts for approximately 15% of acute strokes in the United States and 22–35% in Asian populations [25]. ICH can be a devastating type of stroke, and the 30-day case mortality rate of ICH is 40% to 50%. [2, 6]. A pooled prospective study found that the risk factors for ICH were older age, African-American ethnicity, hypertension, lower LDL-C, and lower triglycerides [7]. ICH has been shown to have important genetic and environmental risk factors.

Apolipoprotein E (APOE) gene, located on the long arm of chromosome 19, codes for a 299-amino acid protein (apoE). ApoE is a polymorphic glycoprotein involved in cholesterol transport and cell membrane maintenance and repair [8, 9]. APOE has three common alleles: epsilon 2 (ϵ2), ϵ3, and ϵ4 that encode the three major isoforms of apoE: E2, E3, and E4, which performs isoform-dependent neurotrophic and antioxidant functions [8, 1012]. Each person has 2 alleles that together compose that person’s APOE genotype (e.g., ϵ2/ϵ3 or ϵ3/ϵ3). APOE is one of the most widely studied genes in vascular and neurodegenerative diseases [13].

Recently, some studies have been conducted to clarify the association between APOE gene polymorphisms and the risk of ICH [1424]. However, previous studies investigating the association have reported conflicting results [25, 26]. We here performed a meta-analysis based on the evidence currently available from the literature to make a more precise estimation of this relationship.

Materials and methods

Literature search strategy

We used a detailed electronic search strategy in Medline and Embase from 1950 to the end of March 2013. Two authors independently searched the databases using following key words in all relevant combinations: ‘cerebral’ or ‘intracerebral’ or ‘intracranial’, ‘hemorrhage’, ‘apolipoprotein E*’ or ‘ApoE*’, ‘polymorphism’ or ‘allele’ or ‘genotype’ or ‘variant’. The search was conducted without limitation on language. The reference lists of all retrieved publications were scrutinized for additional studies. If studies had partially overlapping subjects, the smaller dataset was excluded. If necessary, we attempted to contact the principal investigators of retrieved articles to require additional data.

Inclusion and exclusion criteria

The following criteria were used to include published studies: (i) independent epidemiological studies (for humans only); (ii) a clear description of APOE allele in ICH cases and controls; (iii) sufficient allele data were presented to calculate the odds ratio (OR) and 95% confidence interval (CI); Major reasons for exclusion of studies were (i) no control; (ii) not an original paper (e.g. review or letter etc.); (iii) duplicate publications.

Data extraction

Data were extracted by two authors independently, and disagreements were resolved by consensus. When a study did not explicitly report one or more of the requested data, we contacted the author of the study for additional details. The following data were extracted: the last name of the first author, publication year, country, study design, genotyping method, sample size and the results of studies.

Statistical analysis

All analyses were performed using STATA 11.0 (Stata-Corp LP, College Station, TX, USA). The Mantel-Haenszel method for fixed effects and the Der-Simonian-Laird method for random effects were used to estimate pooled OR and corresponding 95% CI. Meta-analysis heterogeneity was quantified by computing Cochrane’s Q and corresponding P-value and I2 (percent of effect size attributable to heterogeneity). We used fixed-effects methods if the result of the Q test was not significant. Otherwise, we calculated pooled estimates and confidence intervals assuming a random-effects model. Also, subgroup analyses were performed on the basis of race. In this study, P < 0.05 was considered statistically significant. Publication bias was assessed by visual inspection of funnel plots, the Begg's rank correlation method and the Egger's weighted regression method.


Study characteristics

Characteristics of studies included in the meta-analysis are summarized in Table 1. Our initial search identified 108 studies according to the search words. Through the step of screening the title, abstracts, 85 articles were excluded, leaving 23 articles for full publication review. Of these, 12 were excluded [2536]. Finally, a total of 11 studies were included in our meta-analysis [1424], which included 1,238 ICH cases and 3,575 controls. Of those, three studies were population-based case–control studies, and eight studies were hospital-based case–control studies. Studies were conducted in USA, United Kingdom, Portugal, Japan, India and China. The frequencies of apolipoprotein E alleles of studies included in the meta-analysis were shown in Table 2.

Table 1 Characteristics of studies included in the meta-analysis
Table 2 Frequencies of apolipoprotein E alleles of studies included in the meta-analysis

Quantitative synthesis

The combined results based on all studies showed that ICH cases had a significantly higher frequency of APOE ϵ4 allele (OR= 1.42, 95% CI= 1.21,1.67, P<0.001) (Figure 1) (Table 3). In the subgroup analysis by race, we also found that ICH cases had a significantly higher frequency of APOE ϵ4 allele in Asians (OR= 1.52, 95% CI= 1.20,1.93, P<0.001) and in Caucasians (OR= 1.34, 95% CI= 1.07,1.66, P=0.009) (Figure 1) (Table 3). There was no significant relationship between APOE ϵ2 allele and the risk of ICH (Figure 2) (Table 3).

Figure 1

Meta-analysis of APOE alleles and ICH (ϵ4 versus ϵ3).

Table 3 Meta-analysis of apolipoprotein E alleles and intracerebral hemorrhage risk
Figure 2

Meta-analysis of APOE alleles and ICH (ϵ2 versus ϵ3).

Heterogeneity analysis and publication bias

Statistical heterogeneity was not found among studies in overall comparisons by using the Q statistic (Table 3). Publication bias was not found by the Begg's rank correlation method (Figure 3) or Egger weighted regression method (Figure 4).

Figure 3

Begg’s publication bias plot of APOE alleles and ICH.

Figure 4

Egger’s publication bias plot of APOE alleles and ICH.


There is evidence for a role of genetic factors in the development of ICH. Studies investigating the association between genetic polymorphisms and ICH risk are being reported with rapidly increasing frequency. Endoglin gene polymorphism was a risk factor for sporadic ICH [37]. A comparative study that angiotensin converting enzyme (ACE) gene DD homozygosity of the I/D polymorphism in intron 16 is an independent risk factor for ICH in a Polish population [38]. A case–control study suggested that the beta1-tubulin Q43P polymorphism could be associated with ICH in men from southern Spain [39]. A population-based prospective nested case–control study found that estrogen receptor alpha gene polymorphisms were associated with first-ever ICH, particularly in combination with hypertension [40]. A case–control study found that glutathione peroxidase 1 C593T polymorphism was associated with lobar ICH in a Polish population [41]. A case–control study suggested that the rs2228048 of TGFBR2 gene may be associated with development of ICH in Korean population [42]. A study suggested that the rs17222919 of ALOX5AP may be associated with the development of ICH in Korean population [43].

The APOE gene polymorphisms are associated with many other diseases. A meta-analysis showed that APOE ϵ4 allele appeared to be associated with a higher prevalence of dementia in Parkinson disease [44]. A meta-analysis suggested that the APOE ϵ4 isoform was a genetic factor that might influence the age at onset of temporal lobe epilepsy [45]. A meta-analysis showed that the APOE ϵ4 allele was associated with an increased risk of developing hypertension [46]. A meta-analysis found that the APOE ϵ4 allele was associated with a moderately increased risk for progression from mild cognitive impairment to Alzheimer's disease-type dementia [47]. Prevalence of APOE ϵ4 alleles was significantly higher in patients with coronary artery disease than controls [48].

The exact mechanism of the association between APOE polymorphism and the risk of ICH remains unclear. APOE plays a critical role in redistributing lipids among central nervous system cells for normal lipid homeostasis [49], repairing injured neurons [50], maintaining synaptodendritic connections [51], neurite outgrowth [52], synaptic plasticity [53], mitochondrial resistance to oxidative stress [54], and glucose use by neurons and glial cells [25]. Compared with ϵ3/ϵ3, ϵ4 allele-containing genotypes are associated with increased total cholesterol levels [13]. It appears that the ϵ4 allele enhances amyloid deposition in blood vessels [55]. Thus, one might expect ϵ4 carriers to have increased susceptibility to ICH, especially in a lobar location. Furthermore, APOE ϵ4 allele was also associated with an increased risk of developing hypertension [46], which may be the reason that APOE ϵ4 allele was associated with a higher risk of ICH.

Several limitations of our meta-analysis should be noted. First of all, meta-analysis is powerful but also controversial-controversial because several conditions are critical to a sound meta-analysis, and small violations of those conditions can lead to misleading results [56]. Second, relatively small sample size of studies in overall comparisons was observed in this meta-analysis. The results of small meta-analyses should be regarded with caution, even if the P value shows extreme statistical significance [57]. Thirdly, because of the lack of individual patient data, we could not perform an adjustment estimate. In spite of these limitations, our meta-analysis also had some advantages. First, the major strengths of the meta-analysis are that we used a comprehensive searching strategy based on computer-assisted and manual searching which allowed the eligible studies to be included as far as possible. Second, no heterogeneity or publication bias was found, which leads to a possibly robust result.

In conclusion, our meta-analysis suggested that APOE ϵ4 allele was associated with a higher risk of ICH. Future studies will be required to clarify the biological implications of our findings.


  1. 1.

    Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shukla R: The greater Cincinnati/Northern Kentucky stroke study: preliminary first-ever and total incidence rates of stroke among blacks. Stroke. 1998, 29: 415-421. 10.1161/01.STR.29.2.415

  2. 2.

    Qureshi AI, Tuhrim S, Broderick JP, Batjer HH, Hondo H, Hanley DF: Spontaneous intracerebral hemorrhage. N Engl J Med. 2001, 344: 1450-1460. 10.1056/NEJM200105103441907

  3. 3.

    Mohr JP, Caplan LR, Melski JW, Goldstein RJ, Duncan GW, Kistler JP, Pessin MS, Bleich HL: The Harvard cooperative stroke registry: a prospective registry. Neurology. 1978, 28: 754-762. 10.1212/WNL.28.8.754

  4. 4.

    Hu HH, Sheng WY, Chu FL, Lan CF, Chiang BN: Incidence of stroke in Taiwan. Stroke. 1992, 23: 1237-1241. 10.1161/01.STR.23.9.1237

  5. 5.

    Zhang LF, Yang J, Hong Z, Yuan GG, Zhou BF, Zhao LC, Huang YN, Chen J, Wu YF, : Proportion of different subtypes of stroke in China. Stroke. 2003, 34: 2091-2096. 10.1161/01.STR.0000087149.42294.8C

  6. 6.

    Broderick JP, Brott T, Tomsick T, Huster G, Miller R: The risk of subarachnoid and intracerebral hemorrhages in blacks as compared with whites. N Engl J Med. 1992, 326: 733-736. 10.1056/NEJM199203123261103

  7. 7.

    Sturgeon JD, Folsom AR, Longstreth WT, Shahar E, Rosamond WD, Cushman M: Risk factors for intracerebral hemorrhage in a pooled prospective study. Stroke. 2007, 38: 2718-2725. 10.1161/STROKEAHA.107.487090

  8. 8.

    Mahley RW: Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 1988, 240: 622-630. 10.1126/science.3283935

  9. 9.

    Poirier J: Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 1994, 17: 525-530. 10.1016/0166-2236(94)90156-2

  10. 10.

    Al-Khedhairy AA: Apolipoprotein E polymorphism in Saudis. Mol Biol Rep. 2004, 31: 257-260.

  11. 11.

    Mahfouz RA, Sabbagh AS, Zahed LF, Mahfoud ZR, Kalmoni RF, Otrock ZK, Taher AT, Zaatari GS: Apolipoprotein E gene polymorphism and allele frequencies in the Lebanese population. Mol Biol Rep. 2006, 33: 145-149. 10.1007/s11033-006-6260-x

  12. 12.

    Laskowitz DT, Horsburgh K, Roses AD: Apolipoprotein E and the CNS response to injury. J Cereb Blood Flow Metab. 1998, 18: 465-471.

  13. 13.

    Eichner JE, Dunn ST, Perveen G, Thompson DM, Stewart KE, Stroehla BC: Apolipoprotein E polymorphism and cardiovascular disease: a HuGE review. Am J Epidemiol. 2002, 155: 487-495. 10.1093/aje/155.6.487

  14. 14.

    Zhang R, Wang X, Liu J, Yang S, Tang Z, Li S, Peng Y, Zhang H, Yang X, Zhou Y, Shao W: Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage in the Chinese population. Genet Test Mol Biomarkers. 2012, 16: 63-66. 10.1089/gtmb.2011.0103

  15. 15.

    Misra UK, Kalita J, Somarajan BI: Recurrent intracerebral hemorrhage in patients with hypertension is associated with APOE gene polymorphism: a preliminary study. J Stroke Cerebrovasc Dis. 2013, 22: 758-763. 10.1016/j.jstrokecerebrovasdis.2012.02.006

  16. 16.

    Chen YC, Lee-Chen GJ, Wu YR, Hu FJ, Wu HC, Kuo HC, Chu CC, Ryu SJ, Chen ST, Chen CM: Analyses of interaction effect between apolipoprotein E polymorphism and alcohol use as well as cholesterol concentrations on spontaneous deep intracerebral hemorrhage in the Taiwan population. Clin Chim Acta. 2009, 408: 128-132. 10.1016/j.cca.2009.08.004

  17. 17.

    Woo D, Kaushal R, Chakraborty R, Woo J, Haverbusch M, Sekar P, Kissela B, Pancioli A, Jauch E, Kleindorfer D, Flaherty M, Schneider A, Khatri P, Sauerbeck L, Khoury J, Deka R, Broderick J: Association of apolipoprotein E4 and haplotypes of the apolipoprotein E gene with lobar intracerebral hemorrhage. Stroke. 2005, 36: 1874-1879. 10.1161/01.STR.0000177891.15082.b9

  18. 18.

    Woo D, Sauerbeck LR, Kissela BM, Khoury JC, Szaflarski JP, Gebel J, Shukla R, Pancioli AM, Jauch EC, Menon AG, Deka R, Carrozzella JA, Moomaw CJ, Fontaine RN, Broderick JP: Genetic and environmental risk factors for intracerebral hemorrhage: preliminary results of a population-based study. Stroke. 2002, 33: 1190-1195. 10.1161/01.STR.0000014774.88027.22

  19. 19.

    Chowdhury AH, Yokoyama T, Kokubo Y, Zaman MM, Haque A, Tanaka H: Apolipoprotein E genetic polymorphism and stroke subtypes in a Bangladeshi hospital-based study. J Epidemiol. 2001, 11: 131-138. 10.2188/jea.11.131

  20. 20.

    Catto AJ, McCormack LJ, Mansfield MW, Carter AM, Bamford JM, Robinson P, Grant PJ: Apolipoprotein E polymorphism in cerebrovascular disease. Acta Neurol Scand. 2000, 101: 399-404. 10.1034/j.1600-0404.2000.90308a.x

  21. 21.

    Kokubo Y, Chowdhury AH, Date C, Yokoyama T, Sobue H, Tanaka H: Age-dependent association of apolipoprotein E genotypes with stroke subtypes in a Japanese rural population. Stroke. 2000, 31: 1299-1306. 10.1161/01.STR.31.6.1299

  22. 22.

    Garcia C, Pinho e Melo T, Rocha L, Lechner MC: Cerebral hemorrhage and apoE. J Neurol. 1999, 246: 830-834. 10.1007/s004150050463

  23. 23.

    McCarron MO, Nicoll JA: High frequency of apolipoprotein E epsilon 2 allele is specific for patients with cerebral amyloid angiopathy-related haemorrhage. Neurosci Lett. 1998, 247: 45-48. 10.1016/S0304-3940(98)00286-9

  24. 24.

    Nakata Y, Katsuya T, Rakugi H, Takami S, Sato N, Kamide K, Ohishi M, Miki T, Higaki J, Ogihara T: Polymorphism of angiotensin converting enzyme, angiotensinogen, and apolipoprotein E genes in a Japanese population with cerebrovascular disease. Am J Hypertens. 1997, 10: 1391-1395. 10.1016/S0895-7061(97)00315-4

  25. 25.

    Biffi A, Sonni A, Anderson CD, Kissela B, Jagiella JM, Schmidt H, Jimenez-Conde J, Hansen BM, Fernandez-Cadenas I, Cortellini L, Ayres A, Schwab K, Juchniewicz K, Urbanik A, Rost NS, Viswanathan A, Seifert-Held T, Stoegerer EM, Tomas M, Rabionet R, Estivill X, Brown DL, Silliman SL, Selim M, Worrall BB, Meschia JF, Montaner J, Lindgren A, Roquer J, Schmidt R: Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol. 2010, 68: 934-943. 10.1002/ana.22134

  26. 26.

    Sudlow C, Martinez Gonzalez NA, Kim J, Clark C: Does apolipoprotein E genotype influence the risk of ischemic stroke, intracerebral hemorrhage, or subarachnoid hemorrhage? Systematic review and meta-analyses of 31 studies among 5961 cases and 17, 965 controls. Stroke. 2006, 37: 364-370. 10.1161/01.STR.0000199065.12908.62

  27. 27.

    Fontanella M, Rainero I, Gallone S, Rubino E, Rivoiro C, Valfre W, Garbossa D, Nurisso C, Ducati A, Pinessi L: Lack of association between the apolipoprotein E gene and aneurysmal subarachnoid hemorrhage in an Italian population. J Neurosurg. 2007, 106: 245-249. 10.3171/jns.2007.106.2.245

  28. 28.

    Tang J, Zhao J, Zhao Y, Wang S, Chen B, Zeng W: Apolipoprotein E epsilon4 and the risk of unfavorable outcome after aneurysmal subarachnoid hemorrhage. Surg Neurol. 2003, 60: 391-396. discussion 396–397, 10.1016/S0090-3019(03)00323-9

  29. 29.

    Nicoll JA, McCarron MO: APOE gene polymorphism as a risk factor for cerebral amyloid angiopathy-related hemorrhage. Amyloid. 2001, 8 (Suppl 1): 51-55.

  30. 30.

    McCarron MO, Nicoll JA, Stewart J, Ironside JW, Mann DM, Love S, Graham DI, Dewar D: The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. J Neuropathol Exp Neurol. 1999, 58: 711-718. 10.1097/00005072-199907000-00005

  31. 31.

    McCarron MO, Nicoll JA, Ironside JW, Love S, Alberts MJ, Bone I: Cerebral amyloid angiopathy-related hemorrhage. Interaction of APOE epsilon2 with putative clinical risk factors. Stroke. 1999, 30: 1643-1646. 10.1161/01.STR.30.8.1643

  32. 32.

    McCarron MO, Hoffmann KL, DeLong DM, Gray L, Saunders AM, Alberts MJ: Intracerebral hemorrhage outcome: apolipoprotein E genotype, hematoma, and edema volumes. Neurology. 1999, 53: 2176-2179. 10.1212/WNL.53.9.2176

  33. 33.

    Nicoll JA, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, Stewart J, Vinters HV: High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Ann Neurol. 1997, 41: 716-721. 10.1002/ana.410410607

  34. 34.

    Nicoll JA, Burnett C, Love S, Graham DI, Ironside JW, Vinters HV: High frequency of apolipoprotein E epsilon 2 in patients with cerebral hemorrhage due to cerebral amyloid angiopathy. Ann Neurol. 1996, 39: 682-683.

  35. 35.

    Greenberg SM, Briggs ME, Hyman BT, Kokoris GJ, Takis C, Kanter DS, Kase CS, Pessin MS: Apolipoprotein E epsilon 4 is associated with the presence and earlier onset of hemorrhage in cerebral amyloid angiopathy. Stroke. 1996, 27: 1333-1337. 10.1161/01.STR.27.8.1333

  36. 36.

    Greenberg SM, Rebeck GW, Vonsattel JP, Gomez-Isla T, Hyman BT: Apolipoprotein E epsilon 4 and cerebral hemorrhage associated with amyloid angiopathy. Ann Neurol. 1995, 38: 254-259. 10.1002/ana.410380219

  37. 37.

    Alberts MJ, Davis JP, Graffagnino C, McClenny C, Delong D, Granger C, Herbstreith MH, Boteva K, Marchuk DA, Roses AD: Endoglin gene polymorphism as a risk factor for sporadic intracerebral hemorrhage. Ann Neurol. 1997, 41: 683-686. 10.1002/ana.410410519

  38. 38.

    Slowik A, Turaj W, Dziedzic T, Haefele A, Pera J, Malecki MT, Glodzik-Sobanska L, Szermer P, Figlewicz DA, Szczudlik A: DD genotype of ACE gene is a risk factor for intracerebral hemorrhage. Neurology. 2004, 63: 359-361. 10.1212/01.WNL.0000130200.12993.0C

  39. 39.

    Navarro-Nunez L, Lozano ML, Rivera J, Corral J, Roldan V, Gonzalez-Conejero R, Iniesta JA, Montaner J, Vicente V, Martinez C: The association of the beta1-tubulin Q43P polymorphism with intracerebral hemorrhage in men. Haematologica. 2007, 92: 513-518. 10.3324/haematol.10689

  40. 40.

    Strand M, Soderstrom I, Wiklund PG, Hallmans G, Weinehall L, Soderberg S, Olsson T: Estrogen receptor alpha gene polymorphisms and first-ever intracerebral hemorrhage. Cerebrovasc Dis. 2007, 24: 500-508. 10.1159/000110419

  41. 41.

    Pera J, Slowik A, Dziedzic T, Pulyk R, Wloch D, Szczudlik A: Glutathione peroxidase 1 C593T polymorphism is associated with lobar intracerebral hemorrhage. Cerebrovasc Dis. 2008, 25: 445-449. 10.1159/000126918

  42. 42.

    Lim YH, Jeong YS, Kim SK, Kim DH, Yun DH, Yoo SD, Kim HS, Baik HH: Association between TGFBR2 gene polymorphism (rs2228048, Asn389Asn) and intracerebral hemorrhage in Korean population. Immunol Invest. 2011, 40: 569-580. 10.3109/08820139.2011.559498

  43. 43.

    Kim DH, Ahn WY, Kim DK, Choe BK, Kim SK, Jo DJ, Kim JY, Chung JH, Jeong YS, Yun DH, Yoo SD, Kim HS, Baik HH: A Promoter polymorphism (rs17222919, -1316T/G) of ALOX5AP is associated with intracerebral hemorrhage in Korean population. Prostaglandins Leukot Essent Fatty Acids. 2011, 85: 115-120. 10.1016/j.plefa.2011.07.004

  44. 44.

    Huang X, Chen P, Kaufer DI, Troster AI, Poole C: Apolipoprotein E and dementia in Parkinson disease: a meta-analysis. Arch Neurol. 2006, 63: 189-193. 10.1001/archneur.63.2.189

  45. 45.

    Kauffman MA, Consalvo D, Moron DG, Lereis VP, Kochen S: ApoE epsilon4 genotype and the age at onset of temporal lobe epilepsy: a case–control study and meta-analysis. Epilepsy Res. 2010, 90: 234-239. 10.1016/j.eplepsyres.2010.05.007

  46. 46.

    Niu W, Qi Y, Qian Y, Gao P, Zhu D: The relationship between apolipoprotein E epsilon2/epsilon3/epsilon4 polymorphisms and hypertension: a meta-analysis of six studies comprising 1812 cases and 1762 controls. Hypertens Res. 2009, 32: 1060-1066. 10.1038/hr.2009.164

  47. 47.

    Elias-Sonnenschein LS, Viechtbauer W, Ramakers IH, Verhey FR, Visser PJ: Predictive value of APOE-epsilon 4 allele for progression from MCI to AD-type dementia: a meta-analysis. J Neurol Neurosurg Psychiatry. 2011, 82: 1149-1156. 10.1136/jnnp.2010.231555

  48. 48.

    Rai TS, Khullar M, Sehrawat BS, Ahuja M, Sharma PK, Vijayvergiya R, Grover A: Synergistic effect between apolipoprotein E and apolipoprotein A1 gene polymorphisms in the risk for coronary artery disease. Mol Cell Biochem. 2008, 313: 139-146. 10.1007/s11010-008-9751-3

  49. 49.

    Gong JS, Kobayashi M, Hayashi H, Zou K, Sawamura N, Fujita SC, Yanagisawa K, Michikawa M: Apolipoprotein E (ApoE) isoform-dependent lipid release from astrocytes prepared from human ApoE3 and ApoE4 knock-in mice. J Biol Chem. 2002, 277: 29919-29926. 10.1074/jbc.M203934200

  50. 50.

    Buttini M, Orth M, Bellosta S, Akeefe H, Pitas RE, Wyss-Coray T, Mucke L, Mahley RW: Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration. J Neurosci. 1999, 19: 4867-4880.

  51. 51.

    Nathan BP, Bellosta S, Sanan DA, Weisgraber KH, Mahley RW, Pitas RE: Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science. 1994, 264: 850-852. 10.1126/science.8171342

  52. 52.

    Bellosta S, Nathan BP, Orth M, Dong LM, Mahley RW, Pitas RE: Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth. J Biol Chem. 1995, 270: 27063-27071. 10.1074/jbc.270.45.27063

  53. 53.

    Trommer BL, Shah C, Yun SH, Gamkrelidze G, Pasternak ES, Ye GL, Sotak M, Sullivan PM, Pasternak JF, LaDu MJ: ApoE isoform affects LTP in human targeted replacement mice. Neuroreport. 2004, 15: 2655-2658. 10.1097/00001756-200412030-00020

  54. 54.

    Gibson GE, Haroutunian V, Zhang H, Park LC, Shi Q, Lesser M, Mohs RC, Sheu RK, Blass JP: Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype. Ann Neurol. 2000, 48: 297-303. 10.1002/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z

  55. 55.

    McCarron MO, Nicoll JA: Apolipoprotein E genotype and cerebral amyloid angiopathy-related hemorrhage. Ann N Y Acad Sci. 2000, 903: 176-179. 10.1111/j.1749-6632.2000.tb06366.x

  56. 56.

    Walker E, Hernandez AV, Kattan MW: Meta-analysis: Its strengths and limitations. Cleve Clin J Med. 2008, 75: 431-439. 10.3949/ccjm.75.6.431

  57. 57.

    Flather MD, Farkouh ME, Pogue JM, Yusuf S: Strengths and limitations of meta-analysis: larger studies may be more reliable. Control Clin Trials. 1997, 18: 568-579. discussion 661–566, 10.1016/S0197-2456(97)00024-X

Download references


The study was supported by grants from the national key Technology R&D program for the 12th Five-year plan of P.R. China (2011BAI08B05).

Author information

Correspondence to Xiaofeng Wang.

Additional information

Competing interests

The authors declare that they have no conflict of interests.

Authors’ contributions

RJZ, XFW, ZCT, JXL, SZY and YBZ carried out the search studies and drafted the manuscript. YJW, WYL and JW, participated in the design of the study and performed the statistical analysis. JLL, BBC and KHZ conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

Authors’ original submitted files for images

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Zhang, R., Wang, X., Tang, Z. et al. Apolipoprotein E gene polymorphism and the risk of intracerebral hemorrhage: a meta-analysis of epidemiologic studies. Lipids Health Dis 13, 47 (2014) doi:10.1186/1476-511X-13-47

Download citation


  • Apolipoprotein E
  • Intracerebral hemorrhage
  • Gene polymorphism
  • Meta-analysis